Hosted on MSN53m
Jazz Pharmaceuticals (NASDAQ:JAZZ) Surprises With Q4 SalesBiopharma company Jazz Pharmaceuticals (NASDAQ:JAZZ) in Q4 CY2024, with sales up 7.5% year on year to $1.09 billion. On the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback